KLK3 and Familial prostate cancer: We have previously shown that incorporating peripheral blood immune phenotyping-based features into a computation-based prediction tool enables the better detection of prostate cancer and, furthermore, strengthens the accuracy of the PSA test in asymptomatic individuals having PSA levels < 20 ng/ml (Cosma et al., 2017).